| Neuronal surface antibody-mediated encephalopathy as manifestation of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation M Pirotte, F Forte, L Lutteri, E Willems, U Duran, L Belle, F Baron, ... Journal of Neuroimmunology 323, 115-118, 2018 | 18 | 2018 |
| Granulomatosis with polyangiitis in a patient on programmed death-1 inhibitor for advanced non-small-cell lung cancer A Sibille, R Alfieri, O Malaise, N Detrembleur, M Pirotte, R Louis, ... Frontiers in Oncology 9, 478, 2019 | 16 | 2019 |
| Anemia in patients with severe chronic obstructive pulmonary disease, a comorbity more common than previously thought M Pirotte, J Guiot, Y Beguin, R Louis Revue Medicale de Liege 71 (11), 488-494, 2016 | 7 | 2016 |
| Erythroferrone and hepcidin as mediators between erythropoiesis and iron metabolism during allogeneic hematopoietic stem cell transplant M Pirotte, M Fillet, L Seidel, A Jaspers, F Baron, Y Beguin American Journal of Hematology 96 (10), 1275-1286, 2021 | 6 | 2021 |
| B01 venetoclax targeted therapy in AL amyloidosis patients: a retrospective analysis from the French Amyloidosis Network M Roussel, M Pirotte, R Gounot, K Queru, O Rizzo, B Royer, S Harel, ... HemaSphere 7 (S2), 4, 2023 | 2 | 2023 |
| L'anémie dans la bronchopneumopathie chronique obstructive sévère: une comorbidité plus fréquente que l'on ne croit M Pirotte, J GUIOT, Y BEGUIN, R Louis Revue Médicale de Liège 71 (11), 2016 | 2 | 2016 |
| Venetoclax-targeted therapy in t (11; 14) AL amyloidosis patients after frontline daratumumab and cybord: a retrospective analysis from the French amyloidosis network M Roussel, M Pirotte, O Rizzo, K Queru, T Chalopin, O Decaux, E Desport, ... Blood 140 (Supplement 1), 10086-10087, 2022 | 1 | 2022 |
| Overall Survival Rate in Allogeneic Stem Cell Transplanted Patients Requiring Intensive Care Can Be Predicted by the Prognostic Index for Critically Ill Allogeneic … A De Voeght, E Willems, S Servais, L Seidel, M Pirotte, P Massion, ... Cancers 14 (17), 4266, 2022 | 1 | 2022 |
| Prognostic value of visual IMPeTUs criteria and metabolic tumor burden at baseline [18F]FDG PET/CT in patients with newly diagnosed multiple myeloma S Marchiori, F Cousin, I Papadopoulos, C Bernard, M Thys, B De Prijck, ... EJNMMI research 14 (1), 51, 2024 | | 2024 |
| Detailed investigation of erythropoiesis and iron metabolism in the context of allogeneic hematopoietic stem cell transplantation M Pirotte ULiège-Université de Liège [Médecine], Liège, Belgium, 2024 | | 2024 |
| Alterations of erythropoiesis in Covid-19 patients: prevalence of positive Coombs tests and iron metabolism L Schmitz, M Pirotte, A Lebeau, M Ernst, M Fillet, A Devey, J Schmitt, ... Therapeutic Advances in Hematology 14, 20406207231199837, 2023 | | 2023 |
| Vous n’avez pas le monopole du cœur, cas rapporté d’AL neurologique M Pirotte, O Rizzo, M Roussel, A Jaccard Revue Tribune'K Hémato, 2022 | | 2022 |
| Amylose AL O Rizzo, M Pirotte, M Roussel, A Jaccard Correspondances en Onco-Hématologie 16 (novembre-décembre), 2021 | | 2021 |
| Multiple myeloma: an overview of advances in biology and treatment L Vrancken, M Lejeune, M Pirotte, E Duray, M Köse, Y Beguin, J Caers Revue Medicale de Liege 76 (5-6), 482-487, 2021 | | 2021 |
| Le myélome multiple: un tour d’horizon des nouveautés dans sa biologie et son traitement L Vrancken, M Lejeune, M PIROTTE, E Duray, MC Köse, Y BEGUIN, ... Revue Médicale de Liège 76, 2021 | | 2021 |
| Ce n'était pas une myasthénie M Pirotte, A Delens, C Wahlen, F DOME, T Couvreur, L Guillevin, ... Vaisseaux, Coeur, Poumons 21, 2016 | | 2016 |
